Denali Therapeutics buy melinda
Start price
02.08.18
/
50%
?12.15
Target price
29.08.18
€16.15
Performance (%)
33.63%
End price
29.08.18
€16.24
Summary
This prediction ended on 29.08.18 with a price of €16.24. With a performance of 33.63% the BUY prediction by melinda was a big success. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Denali Therapeutics | - | - | - | - |
| iShares Core DAX® | 1,01 % | 2,70 % | 4,36 % | 51,69 % |
| iShares Nasdaq 100 | -6,47 % | -8,77 % | 18,00 % | 67,99 % |
| iShares Nikkei 225® | -6,52 % | -12,58 % | 40,91 % | 57,11 % |
| iShares S&P 500 | -2,72 % | -1,75 % | 16,97 % | 58,87 % |
Comments by melinda for this prediction
In the thread Denali Therapeutics diskutieren
SecteurRecherche biotechnologique et médicale
$ DNLI annonce les résultats cliniques positifs du programme d'inhibiteurs LRRK2 pour la maladie de Parkinson
(Vom Mitglied beendet)